Reference
Malvankar-Mehta MS, et al. North American cost analysis of brand name versus generic drugs for the treatment of glaucoma. ClinicoEconomics and Outcomes Research 2019: 789-798, No. 11, 16 Dec 2019. Available from: URL: https://doi.org/10.2147/CEOR.S156558
Rights and permissions
About this article
Cite this article
Brand-name drugs for glaucoma more costly than generics. PharmacoEcon Outcomes News 844, 9 (2020). https://doi.org/10.1007/s40274-020-6472-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6472-7